1. Results of a Phase 1/2a dose–escalation study of FF-10501-01, an IMPDH inhibitor, in patients with acute myeloid leukemia or myelodysplastic syndromes. Issue 8 (2nd July 2020) Authors: Garcia-Manero, Guillermo; Pemmaraju, Naveen; Alvarado, Yesid; Naqvi, Kiran; Ravandi, Farhad; Jabbour, Elias; De Lumpa, Ricardo; Kantarjian, Hagop; Advani, Anjali; Mukherjee, Sudipto; Gerds, Aaron; Carraway, Hetty E.; Nazha, Aziz; Iwamura, Hiroyuki; Murase, Motohiko; Bavisotto, Linda; Kurman, Mich... Journal: Leukemia & lymphoma Issue: Volume 61:Issue 8(2020) Page Start: 1943 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗